1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > Generic Drug Analysis & Statistics, January 2016 (p30)

Generic Drug Analysis & Statistics, January 2016 (p30)

871-900 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Paricalcitol  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Paricalcitol - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Exenatide  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Exenatide - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Etanercept  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Etanercept - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug, Therapy
Levosimendan  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Levosimendan - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ipilimumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Ipilimumab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Nivolumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Nivolumab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ipilimumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Ipilimumab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Etanercept  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Etanercept - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug, Therapy
Tulathromycin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Tulathromycin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ustekinumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Ustekinumab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Fampridine  - Comprehensive patent search

Fampridine - Comprehensive patent search

  • $ 8 160
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

  • Industries : Generic Drug
Brentuximab Vedotin  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Brentuximab Vedotin - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Dasabuvir  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Dasabuvir - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Tulathromycin  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Tulathromycin - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Alendronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Alendronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Levosimendan  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Levosimendan - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Brentuximab Vedotin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Brentuximab Vedotin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Fampridine  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Fampridine - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Alemtuzumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Alemtuzumab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Dasabuvir  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Dasabuvir - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Blinatumomab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Blinatumomab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Alemtuzumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Alemtuzumab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Exenatide  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Exenatide - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Alendronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Alendronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Fampridine  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Fampridine - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ofatumumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Ofatumumab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Pembrolizumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Pembrolizumab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Blinatumomab  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Blinatumomab - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Pembrolizumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Pembrolizumab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ustekinumab  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Ustekinumab - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.